NCT06152055 Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal Status COMPLETED Phase N/A
NCT06148077 Manual Therapy on Oral Opening, Swallow Function and Upper Quarter Mobility on Head and Neck Cancer Survivors Status RECRUITING Phase NA
NCT06145412 A Study of Xevinapant With Cisplatin and Radiation Therapy After Surgery in People With Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT06133790 Profiles of Expression in HPV+ Versus HPV Head and Neck Cancers Status WITHDRAWN Phase N/A
NCT06127784 Survivorship After HNC: A Randomized Controlled Trial Evaluating Patient Care and Adherence to Follow-up Status RECRUITING Phase NA
NCT06124508 PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors Status RECRUITING Phase NA
NCT06116019 Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS) Status RECRUITING Phase N/A
NCT06110195 Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer Status TERMINATED Phase PHASE1
NCT06108089 Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment Status RECRUITING Phase N/A
NCT06103669 Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS) Status RECRUITING Phase NA
NCT06103617 Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer Status RECRUITING Phase PHASE2
NCT06096038 Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC Status RECRUITING Phase PHASE1
NCT06094985 Prognostic Markers for a Better Follow-up in Head and Neck Cancer. Status RECRUITING Phase N/A
NCT06094621 Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery Status WITHDRAWN Phase N/A
NCT06091930 A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6 Status TERMINATED Phase PHASE1
NCT06088381 Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL) Status RECRUITING Phase PHASE2
NCT06056310 Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX) Status TERMINATED Phase PHASE1
NCT06054477 Study of ALE.C04 in Patients With Head and Neck Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT06052852 Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies Status TERMINATED Phase PHASE1